<iframe src="//www.googletagmanager.com/ns.html?id=GTM-5TSRKG" height="0" width="0" style="display: none; visibility: hidden">
Research Article
No access
Published Online: 9 August 2012

SARS-CoV Regulates Immune Function-Related Gene Expression in Human Monocytic Cells

Publication: Viral Immunology
Volume 25, Issue Number 4

Abstract

Severe acute respiratory syndrome (SARS) is characterized by acute respiratory distress syndrome (ARDS) and pulmonary fibrosis, and monocytes/macrophages are the key players in the pathogenesis of SARS. In this study, we compared the transcriptional profiles of SARS coronavirus (SARS-CoV)-infected monocytic cells against that infected by coronavirus 229E (CoV-229E). Total RNA was extracted from infected DC-SIGN-transfected monocytes (THP-1-DC-SIGN) at 6 and 24 h after infection, and the gene expression was profiled in oligonucleotide-based microarrays. Analysis of immune-related gene expression profiles showed that at 24 h after SARS-CoV infection: (1) IFN-α/β-inducible and cathepsin/proteasome genes were downregulated; (2) hypoxia/hyperoxia-related genes were upregulated; and (3) TLR/TLR-signaling, cytokine/cytokine receptor-related, chemokine/chemokine receptor-related, lysosome-related, MHC/chaperon-related, and fibrosis-related genes were differentially regulated. These results elucidate that SARS-CoV infection regulates immune-related genes in monocytes/macrophages, which may be important to the pathogenesis of SARS.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Abdollahi ALi MPing G et al. Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosisJ Exp Med2005201925-935. 1. Abdollahi A, Li M, Ping G, et al.: Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med 2005;201:925–935.
2.
Amer AOSwanson MS. A phagosome of one's own: a microbial guide to life in the macrophageCurr Opin Microbiol2002556-61. 2. Amer AO and Swanson MS: A phagosome of one's own: a microbial guide to life in the macrophage. Curr Opin Microbiol 2002;5:56–61.
3.
Antonio GEWong KTHui DS et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experienceRadiology2003228810-815. 3. Antonio GE, Wong KT, Hui DS, et al.: Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology 2003;228:810–815.
4.
Bitterman PBWewers MDRennard SIAdelberg SCrystal RG. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediatorsJ Clin Invest198677700-708. 4. Bitterman PB, Wewers MD, Rennard SI, Adelberg S, and Crystal RG: Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J Clin Invest 1986;77:700–708.
5.
Bleharski JRLi HMeinken C et al. Use of genetic profiling in leprosy to discriminate clinical forms of the diseaseScience20033011527-1530. 5. Bleharski JR, Li H, Meinken C, et al.: Use of genetic profiling in leprosy to discriminate clinical forms of the disease. Science 2003;301:1527–1530.
6.
Charo IFRansohoff RM. The many roles of chemokines and chemokine receptors in inflammationN Engl J Med2006354610-621. 6. Charo IF and Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610–621.
7.
Chen JSubbarao K. The immunobiology of SARS*Annu Rev Immunol200725443-472. 7. Chen J and Subbarao K: The immunobiology of SARS*. Annu Rev Immunol 2007;25:443–472.
8.
Cheung CYPoon LLLau AS et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?Lancet20023601831-1837. 8. Cheung CY, Poon LL, Lau AS, et al.: Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002;360:1831–1837.
9.
Cheung CYPoon LLNg IH et al. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesisJ Virol2005797819-7826. 9. Cheung CY, Poon LL, Ng IH, et al.: Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 2005;79:7819–7826.
10.
Clark JGMilberg JASteinberg KPHudson LD. Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for deathAnn Intern Med199512217-23. 10. Clark JG, Milberg JA, Steinberg KP, and Hudson LD: Type III procollagen peptide in the adult respiratory distress syndrome. Association of increased peptide levels in bronchoalveolar lavage fluid with increased risk for death. Ann Intern Med 1995;122:17–23.
11.
Dentener MABazil VVon Asmuth EJCeska MBuurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophagesJ Immunol19931502885-2891. 11. Dentener MA, Bazil V, Von Asmuth EJ, Ceska M, and Buurman WA: Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993;150:2885–2891.
12.
Eickhoff MThalmann JHess S et al. Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolismInfect Immun2007752853-2863. 12. Eickhoff M, Thalmann J, Hess S, et al.: Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism. Infect Immun 2007;75:2853–2863.
13.
El-Sahly HMAtmar RLGlezen WPGreenberg SB. Spectrum of clinical illness in hospitalized patients with “common cold” virus infectionsClin Infect Dis20003196-100. 13. El-Sahly HM, Atmar RL, Glezen WP, and Greenberg SB: Spectrum of clinical illness in hospitalized patients with “common cold” virus infections. Clin Infect Dis 2000;31:96–100.
14.
Elliott TNeefjes J. The complex route to MHC class I-peptide complexesCell2006127249-251. 14. Elliott T and Neefjes J: The complex route to MHC class I-peptide complexes. Cell 2006;127:249–251.
15.
Grinblat LShulman HGlickman AMatukas LPaul N. Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, CanadaRadiology2003228802-809. 15. Grinblat L, Shulman H, Glickman A, Matukas L, and Paul N: Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. Radiology 2003;228:802–809.
16.
Gupta NRao PV. Transcriptomic profile of host response in Japanese encephalitis virus infectionVirol J2011892. 16. Gupta N and Rao PV: Transcriptomic profile of host response in Japanese encephalitis virus infection. Virol J 2011;8:92.
17.
Hakansson LVenge P. The combined action of hyaluronic acid and fibronectin stimulates neutrophil migrationJ Immunol19851352735-2739. 17. Hakansson L and Venge P: The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J Immunol 1985;135:2735–2739.
18.
Hattori NMizuno SYoshida Y et al. The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanismAm J Pathol20041641091-1098. 18. Hattori N, Mizuno S, Yoshida Y, et al.: The plasminogen activation system reduces fibrosis in the lung by a hepatocyte growth factor-dependent mechanism. Am J Pathol 2004;164:1091–1098.
19.
Heil FHemmi HHochrein H et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8Science20043031526-1529. 19. Heil F, Hemmi H, Hochrein H, et al.: Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526–1529.
20.
Hodges RJJenkins RGWheeler-Jones CP et al. Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) productionAm J Pathol20041651663-1676. 20. Hodges RJ, Jenkins RG, Wheeler-Jones CP, et al.: Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production. Am J Pathol 2004;165:1663–1676.
21.
Hsing LCRudensky AY. The lysosomal cysteine proteases in MHC class II antigen presentationImmunol Rev2005207229-241. 21. Hsing LC and Rudensky AY: The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 2005;207:229–241.
22.
Hsueh PRHsiao CHYeh SH et al. Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, TaiwanEmerg Infect Dis200391163-1167. 22. Hsueh PR, Hsiao CH, Yeh SH, et al.: Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 2003;9:1163–1167.
23.
Iwasaki AMedzhitov R. Toll-like receptor control of the adaptive immune responsesNat Immunol20045987-995. 23. Iwasaki A and Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987–995.
24.
Jiang DLiang JFan J et al. Regulation of lung injury and repair by toll-like receptors and hyaluronanNat Med2005111173-1179. 24. Jiang D, Liang J, Fan J, et al.: Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med 2005;11:1173–1179.
25.
Kanayama NKajiwara YGoto Jel Maradny EMaehara KAndou KTerao T. Inactivation of interleukin-8 by aminopeptidase N (CD13)J Leukoc Biol199557129-134. 25. Kanayama N, Kajiwara Y, Goto J, el Maradny E, Maehara K, Andou K, and Terao T: Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 1995;57:129–134.
26.
Kariko KBuckstein MNi HWeissman D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNAImmunity200523165-175. 26. Kariko K, Buckstein M, Ni H, and Weissman D: Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005;23:165–175.
27.
Kim KHBurkhart KChen P et al. Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed miceAm J Respir Cell Mol Biol200533271-279. 27. Kim KH, Burkhart K, Chen P, et al.: Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am J Respir Cell Mol Biol 2005;33:271–279.
28.
Kotani ISato AHayakawa HUrano TTakada YTakada A. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosisThromb Res199577493-504. 28. Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, and Takada A: Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res 1995;77:493–504.
29.
Lam BKPenrose JFFreeman GJAusten KF. Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4Proc Natl Acad Sci USA1994917663-7667. 29. Lam BK, Penrose JF, Freeman GJ, and Austen KF: Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci USA 1994;91:7663–7667.
30.
Lau YLPeiris JS. Pathogenesis of severe acute respiratory syndromeCurr Opin Immunol200517404-410. 30. Lau YL and Peiris JS: Pathogenesis of severe acute respiratory syndrome. Curr Opin Immunol 2005;17:404–410.
31.
Lee YChen CChao AChen EWei M. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV)BMC Genomics200561-10. 31. Lee Y, Chen C, Chao A, Chen E, and Wei M: Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005;6:1–10.
32.
Lund JMAlexopoulou LSato A et al. Recognition of single-stranded RNA viruses by toll-like receptor 7Proc Natl Acad Sci USA20041015598-5603. 32. Lund JM, Alexopoulou L, Sato A, et al.: Recognition of single-stranded RNA viruses by toll-like receptor 7. Proc Natl Acad Sci USA 2004;101:5598–5603.
33.
McKee CMPenno MBCowman MBurdick MDStrieter RMBao CNoble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44J Clin Invest1996982403-2413. 33. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, and Noble PW: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996;98:2403–2413.
34.
Minami MOhno SKawasaki H et al. Molecular cloning of a cDNA coding for human leukotriene A4 hydrolase. Complete primary structure of an enzyme involved in eicosanoid synthesisJ Biol Chem198726213873-13876. 34. Minami M, Ohno S, Kawasaki H, et al.: Molecular cloning of a cDNA coding for human leukotriene A4 hydrolase. Complete primary structure of an enzyme involved in eicosanoid synthesis. J Biol Chem 1987;262:13873–13876.
35.
Mossman KL. Activation and inhibition of virus and interferon: the herpesvirus storyViral Immunol2002153-15. 35. Mossman KL: Activation and inhibition of virus and interferon: the herpesvirus story. Viral Immunol 2002;15:3–15.
36.
Nicholls JMPoon LLLee KC et al. Lung pathology of fatal severe acute respiratory syndromeLancet20033611773-1778. 36. Nicholls JM, Poon LL, Lee KC, et al.: Lung pathology of fatal severe acute respiratory syndrome. Lancet 2003;361:1773–1778.
37.
Ockenhouse CFHu WCKester KE et al. Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malariaInfect Immun2006745561-5573. 37. Ockenhouse CF, Hu WC, Kester KE, et al.: Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria. Infect Immun 2006;74:5561–5573.
38.
Overath PAebischer T. Antigen presentation by macrophages harboring intravesicular pathogensParasitol Today199915325-332. 38. Overath P and Aebischer T: Antigen presentation by macrophages harboring intravesicular pathogens. Parasitol Today 1999;15:325–332.
39.
Palmblad JMalmsten CLUden AMRadmark OEngstedt LSamuelsson B. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherenceBlood198158658-661. 39. Palmblad J, Malmsten CL, Uden AM, Radmark O, Engstedt L, and Samuelsson B: Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 1981;58:658–661.
40.
Peiris JSChu CMCheng VC et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective studyLancet20033611767-1772. 40. Peiris JS, Chu CM, Cheng VC, et al.: Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003;361:1767–1772.
41.
Peters-Golden MBailie MMarshall TWilke CPhan SHToews GBMoore BB. Protection from pulmonary fibrosis in leukotriene-deficient miceAm J Respir Crit Care Med2002165229-235. 41. Peters-Golden M, Bailie M, Marshall T, Wilke C, Phan SH, Toews GB, and Moore BB: Protection from pulmonary fibrosis in leukotriene-deficient mice. Am J Respir Crit Care Med 2002;165:229–235.
42.
Plager DALoegering DAWeiler DA et al. A novel and highly divergent homolog of human eosinophil granule major basic proteinJ Biol Chem199927414464-14473. 42. Plager DA, Loegering DA, Weiler DA, et al.: A novel and highly divergent homolog of human eosinophil granule major basic protein. J Biol Chem 1999;274:14464–14473.
43.
Ramilo OAllman WChung W et al. Gene expression patterns in blood leukocytes discriminate patients with acute infectionsBlood20071092066-2077. 43. Ramilo O, Allman W, Chung W, et al.: Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 2007;109:2066–2077.
44.
Reghunathan RJayapal MHsu LYChng HHTai DLeung BPMelendez AJ. Expression profile of immune response genes in patients with severe acute respiratory syndromeBMC Immunol200562. 44. Reghunathan R, Jayapal M, Hsu LY, Chng HH, Tai D, Leung BP, and Melendez AJ: Expression profile of immune response genes in patients with severe acute respiratory syndrome. BMC Immunol 2005;6:2.
45.
Ruddy MJWong GCLiu XKYamamoto HKasayama SKirkwood KLGaffen SL. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family membersJ Biol Chem20042792559-2567. 45. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, and Gaffen SL: Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 2004;279:2559–2567.
46.
Ruiz VOrdonez RMBerumen J et al. Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosisAm J Physiol Lung Cell Mol Physiol2003285L1026-L1036. 46. Ruiz V, Ordonez RM, Berumen J, et al.: Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2003;285:L1026–L1036.
47.
Samuel CE. Antiviral actions of interferonsClin Microbiol Rev200114778-809table of contents. 47. Samuel CE: Antiviral actions of interferons. Clin Microbiol Rev 2001;14:778–809, table of contents.
48.
Schoenemeyer ABarnes BJMancl ME et al. The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signalingJ Biol Chem200528017005-17012. 48. Schoenemeyer A, Barnes BJ, Mancl ME, et al.: The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 2005;280:17005–17012.
49.
Siegbahn AHammacher AWestermark BHeldin CH. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytesJ Clin Invest199085916-920. 49. Siegbahn A, Hammacher A, Westermark B, and Heldin CH: Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest 1990;85:916–920.
50.
Skowronski DMAstell CBrunham RC et al. Severe acute respiratory syndrome (SARS): a year in reviewAnnu Rev Med200556357-381. 50. Skowronski DM, Astell C, Brunham RC, et al.: Severe acute respiratory syndrome (SARS): a year in review. Annu Rev Med 2005;56:357–381.
51.
Soilleux EJMorris LSLeslie G et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitroJ Leukoc Biol200271445-457. 51. Soilleux EJ, Morris LS, Leslie G, et al.: Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002;71:445–457.
52.
Spiegel MWeber F. Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirusVirol J2006317. 52. Spiegel M and Weber F: Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. Virol J 2006;3:17.
53.
Stern RAsari AASugahara KN. Hyaluronan fragments: an information-rich systemEur J Cell Biol200685699-715. 53. Stern R, Asari AA, and Sugahara KN: Hyaluronan fragments: an information-rich system. Eur J Cell Biol 2006;85:699–715.
54.
Tsai MHYan HChen X et al. Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarraysMol Biotechnol200529221-224. 54. Tsai MH, Yan H, Chen X, et al.: Evaluation of hybridization conditions for spotted oligonucleotide-based DNA microarrays. Mol Biotechnol 2005;29:221–224.
55.
Unanue ERBeller DICalderon JKiely JMStadecker MJ. Regulation of immunity and inflammation by mediators from macrophagesAm J Pathol197685465-478. 55. Unanue ER, Beller DI, Calderon J, Kiely JM, and Stadecker MJ: Regulation of immunity and inflammation by mediators from macrophages. Am J Pathol 1976;85:465–478.
56.
van't Wout ABLehrman GKMikheeva SA et al. Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell linesJ Virol2003771392-1402. 56. van't Wout AB, Lehrman GK, Mikheeva SA, et al.: Cellular gene expression upon human immunodeficiency virus type 1 infection of CD4(+)-T-cell lines. J Virol 2003;77:1392–1402.
57.
van Heerden PVBarden AMichalopoulos NBulsara MKRoberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDSChest2000117819-827. 57. van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, and Roberts BL: Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest 2000;117:819–827.
58.
van Kooyk YGeijtenbeek TB. DC-SIGN: escape mechanism for pathogensNat Rev Immunol20033697-709. 58. van Kooyk Y and Geijtenbeek TB: DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003;3:697–709.
59.
Vecchiarelli ARetini CCasadevall AMonari CPietrella DKozel TR. Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformansInfect Immun1998664324-4330. 59. Vecchiarelli A, Retini C, Casadevall A, Monari C, Pietrella D, and Kozel TR: Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans. Infect Immun 1998;66:4324–4330.
60.
Ware LBMatthay MA. The acute respiratory distress syndromeN Engl J Med20003421334-1349. 60. Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000;342:1334–1349.
61.
Warshamana GSMartinez SLasky JACorti MBrody AR. Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferationAm J Physiol1998274L499-L507. 61. Warshamana GS, Martinez S, Lasky JA, Corti M, and Brody AR: Dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation. Am J Physiol 1998;274:L499–L507.
62.
Wu GDLai EJHuang NWen X. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressorJ Biol Chem19972722396-2403. 62. Wu GD, Lai EJ, Huang N, and Wen X: Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin-8 promoter. The role of Oct-1 as a transcriptional repressor. J Biol Chem 1997;272:2396–2403.
63.
Yamamoto MSato SMori KHoshino KTakeuchi OTakeda KAkira S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signalingJ Immunol20021696668-6672. 63. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, and Akira S: Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002;169:6668–6672.
64.
Yen YTLiao FHsiao CHKao CLChen YCWu-Hsieh BA. Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitroJ Virol2006802684-2693. 64. Yen YT, Liao F, Hsiao CH, Kao CL, Chen YC, and Wu-Hsieh BA: Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro. J Virol 2006;80:2684–2693.
65.
Zhu HCong JPMamtora GGingeras TShenk T. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arraysProc Natl Acad Sci USA19989514470-14475. 65. Zhu H, Cong JP, Mamtora G, Gingeras T, and Shenk T: Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc Natl Acad Sci USA 1998;95:14470–14475.
66.
Ziegler TMatikainen SRonkko E et al. Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cellsJ Virol20057913800-13805. 66. Ziegler T, Matikainen S, Ronkko E, et al.: Severe acute respiratory syndrome coronavirus fails to activate cytokine-mediated innate immune responses in cultured human monocyte-derived dendritic cells. J Virol 2005;79:13800–13805.

Information & Authors

Information

Published In

cover image Viral Immunology
Viral Immunology
Volume 25Issue Number 4August 2012
Pages: 277 - 288
PubMed: 22876772

History

Received: 30 December 2012
Published online: 9 August 2012
Published in print: August 2012
Accepted: 10 April 2012

Permissions

Request permissions for this article.

Topics

Authors

Affiliations

Wanchung Hu
Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.
Yu-Ting Yen
Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.
Sher Singh
NTU Center for Genomic Medicine, National Taiwan University Hospital, Taipei, Taiwan, R.O.C.
Chuan-Liang Kao
Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.
Betty A. Wu-Hsieh
Graduate Institute of Immunology, National Taiwan University College of Medicine, Taipei, Taiwan, R.O.C.

Notes

Address correspondence to:Dr. Betty A. Wu-HsiehGraduate Institute of ImmunologyNational Taiwan University College of MedicineNo.1 Jen-Ai Road, Section 1Taipei 100,Taiwan R.O.C.
E-mail: [email protected]

Author Disclosure Statement

No competing financial interests exist.

Metrics & Citations

Metrics

Citations

Export citation

Select the format you want to export the citations of this publication.

View Options

Get Access

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.

Society Access

If you are a member of a society that has access to this content please log in via your society website and then return to this publication.

Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

View options

PDF/EPUB

View PDF/ePub

Full Text

View Full Text

Media

Figures

Other

Tables

Share

Share

Copy the content Link

Share on social media

Topics

Back to Top